Variant report
Variant | nsv980172 |
---|---|
Chromosome Location | chr4:187814588-187819775 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr4:187814906-187815103 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr4:187815245-187815445 | HepG2 | liver: | n/a | n/a |
3 | MAFF | chr4:187814830-187815115 | HepG2 | liver: | n/a | chr4:187814895-187814913 |
4 | MAFK | chr4:187814716-187814912 | HepG2 | liver: | n/a | chr4:187814901-187814912 chr4:187814896-187814911 chr4:187814901-187814912 |
5 | MAFK | chr4:187814819-187815216 | HepG2 | liver: | n/a | chr4:187814901-187814912 chr4:187814896-187814911 chr4:187814901-187814912 |
6 | POLR2A | chr4:187814781-187814922 | K562 | blood: | n/a | n/a |
7 | POLR2A | chr4:187817113-187817313 | K562 | blood: | n/a | n/a |
8 | POLR2A | chr4:187815119-187815299 | K562 | blood: | n/a | n/a |
9 | ZMIZ1 | chr4:187816407-187816483 | K562 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MRPS36P2 | TF binding region |
ENSG00000250829 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185585214 | chr4:187814600-187814601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11933074 | chr4:187814655-187814656 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs369360012 | chr4:187814715-187814716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189225256 | chr4:187814726-187814727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139468869 | chr4:187814730-187814731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559938629 | chr4:187814745-187814746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573601112 | chr4:187814752-187814753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141069691 | chr4:187814760-187814761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368245803 | chr4:187814764-187814765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs34214851 | chr4:187814765-187814766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149658117 | chr4:187814781-187814782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565555221 | chr4:187814802-187814803 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535703509 | chr4:187814823-187814824 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144505962 | chr4:187814837-187814838 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192543827 | chr4:187814855-187814856 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs433477 | chr4:187814866-187814867 | Weak transcription Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs536166010 | chr4:187814883-187814884 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529850088 | chr4:187814887-187814888 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546396215 | chr4:187814888-187814889 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566302895 | chr4:187814923-187814924 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2114143 | chr4:187815001-187815002 | Weak transcription Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs148422959 | chr4:187815006-187815007 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569113322 | chr4:187815023-187815024 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537089170 | chr4:187815045-187815046 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576154460 | chr4:187815054-187815055 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11933236 | chr4:187815056-187815057 | Weak transcription Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs114003292 | chr4:187815059-187815060 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144854577 | chr4:187815066-187815067 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576892377 | chr4:187815083-187815084 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553616490 | chr4:187815090-187815091 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540833642 | chr4:187815138-187815139 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183991149 | chr4:187815144-187815145 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376860 | chr4:187815149-187815150 | Weak transcription Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs559031097 | chr4:187815169-187815170 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs60774688 | chr4:187815174-187815175 | Weak transcription Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs529888986 | chr4:187815203-187815204 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs28410653 | chr4:187815225-187815226 | Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs116188739 | chr4:187815229-187815230 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs11942401 | chr4:187815250-187815251 | Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs11947290 | chr4:187815274-187815275 | Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs181160727 | chr4:187815285-187815286 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs185996893 | chr4:187815299-187815300 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552348325 | chr4:187815331-187815332 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs569064821 | chr4:187815355-187815356 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs430549 | chr4:187815359-187815360 | Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs527314291 | chr4:187815361-187815362 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563823625 | chr4:187815368-187815369 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
48 | rs73025547 | chr4:187815429-187815430 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs567627030 | chr4:187815430-187815431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190154123 | chr4:187815465-187815466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Facioscapulohumeral muscular dystrophy | 21829175 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Autism | 18414403 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 20409316 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Developmental delay | 22127048 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cervical cancer | 21063398 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:187808200-187821400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr4:187811200-187821400 | Weak transcription | K562 | blood |
3 | chr4:187811600-187816200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr4:187813200-187821200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr4:187814800-187815200 | Bivalent/Poised TSS | HepG2 | liver |
6 | chr4:187815200-187815400 | Bivalent Enhancer | HepG2 | liver |
7 | chr4:187816200-187816400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr4:187816400-187829400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr4:187818400-187818600 | Enhancers | HUVEC | blood vessel |
10 | chr4:187818800-187821200 | Weak transcription | HUVEC | blood vessel |